US5741908A
(en)
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
US6518280B2
(en)
|
1998-12-11 |
2003-02-11 |
3M Innovative Properties Company |
Imidazonaphthyridines
|
AU776654B2
(en)
|
1999-01-08 |
2004-09-16 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
US6486168B1
(en)
|
1999-01-08 |
2002-11-26 |
3M Innovative Properties Company |
Formulations and methods for treatment of mucosal associated conditions with an immune response modifier
|
US6558951B1
(en)
*
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6451810B1
(en)
|
1999-06-10 |
2002-09-17 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6541485B1
(en)
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6756382B2
(en)
*
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6573273B1
(en)
|
1999-06-10 |
2003-06-03 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
ATE311385T1
(de)
|
1999-10-27 |
2005-12-15 |
Novartis Pharma Gmbh |
Thiazol und imidazo(4,5-b)pyridin verbindungen und ihre verwendung als pharmazeutika
|
US6376669B1
(en)
|
1999-11-05 |
2002-04-23 |
3M Innovative Properties Company |
Dye labeled imidazoquinoline compounds
|
US6916925B1
(en)
|
1999-11-05 |
2005-07-12 |
3M Innovative Properties Co. |
Dye labeled imidazoquinoline compounds
|
JP3436512B2
(ja)
*
|
1999-12-28 |
2003-08-11 |
株式会社デンソー |
アクセル装置
|
EP1256582A1
(en)
*
|
2000-02-09 |
2002-11-13 |
Hokuriku Seiyaku Co., Ltd. |
1h-imidazopyridine derivatives
|
US6894060B2
(en)
|
2000-03-30 |
2005-05-17 |
3M Innovative Properties Company |
Method for the treatment of dermal lesions caused by envenomation
|
WO2002016370A1
(fr)
*
|
2000-08-22 |
2002-02-28 |
Hokuriku Seiyaku Co., Ltd. |
Derives de 1h-imidazopyridine
|
US6576644B2
(en)
*
|
2000-09-06 |
2003-06-10 |
Bristol-Myers Squibb Co. |
Quinoline inhibitors of cGMP phosphodiesterase
|
EP1320529B1
(en)
*
|
2000-09-21 |
2006-05-24 |
Smithkline Beecham Plc |
Quinoline derivatives as antibacterials
|
US7087224B2
(en)
*
|
2000-10-31 |
2006-08-08 |
Amgen Inc. |
Method of treating anemia by administering IL-1ra
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
EP1850850A4
(en)
*
|
2000-12-08 |
2011-06-15 |
3M Innovative Properties Co |
COMPOSITIONS AND METHOD FOR TARGETED ADMINISTRATION OF IMMUNE RESPONSE MODIFICATORS
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6667312B2
(en)
*
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6677348B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
US6664264B2
(en)
*
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6660747B2
(en)
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
UA75622C2
(en)
*
|
2000-12-08 |
2006-05-15 |
3M Innovative Properties Co |
Aryl ether substituted imidazoquinolines, pharmaceutical composition based thereon
|
US6677347B2
(en)
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6660735B2
(en)
*
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
US7226928B2
(en)
|
2001-06-15 |
2007-06-05 |
3M Innovative Properties Company |
Methods for the treatment of periodontal disease
|
ES2312659T3
(es)
|
2001-11-29 |
2009-03-01 |
3M Innovative Properties Company |
Formulaciones farmaceuticas que comprenden un modificador de la respuesta inmune.
|
CA2365732A1
(en)
|
2001-12-20 |
2003-06-20 |
Ibm Canada Limited-Ibm Canada Limitee |
Testing measurements
|
US6677349B1
(en)
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
SI1478327T1
(sl)
*
|
2002-02-22 |
2015-08-31 |
Meda Ab |
Metoda za zmanjšanje in zdravljenje imunosupresije, inducirane z UV-B
|
US6933294B2
(en)
*
|
2002-04-03 |
2005-08-23 |
Bristol-Myers Squibb Company |
Thiophene-based tricyclic compounds and pharmaceutical compositions comprising same
|
GB0211649D0
(en)
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
CA2488801A1
(en)
|
2002-06-07 |
2003-12-18 |
3M Innovative Properties Company |
Ether substituted imidazopyridines
|
US7427629B2
(en)
|
2002-08-15 |
2008-09-23 |
3M Innovative Properties Company |
Immunostimulatory compositions and methods of stimulating an immune response
|
WO2004028539A2
(en)
*
|
2002-09-26 |
2004-04-08 |
3M Innovative Properties Company |
1h-imidazo dimers
|
WO2004035579A1
(ja)
*
|
2002-10-15 |
2004-04-29 |
Takeda Pharmaceutical Company Limited |
イミダゾピリジン誘導体、その製造法および用途
|
US7563810B2
(en)
*
|
2002-11-06 |
2009-07-21 |
Celgene Corporation |
Methods of using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione for the treatment and management of myeloproliferative diseases
|
CA2504820C
(en)
*
|
2002-11-06 |
2011-08-23 |
Grelan Pharmaceutical Co., Ltd. |
Pyrazolonaphthyridine derivatives
|
US8034831B2
(en)
*
|
2002-11-06 |
2011-10-11 |
Celgene Corporation |
Methods for the treatment and management of myeloproliferative diseases using 4-(amino)-2-(2,6-Dioxo(3-piperidyl)-isoindoline-1,3-dione in combination with other therapies
|
US7091214B2
(en)
|
2002-12-20 |
2006-08-15 |
3M Innovative Properties Co. |
Aryl substituted Imidazoquinolines
|
EP2572714A1
(en)
|
2002-12-30 |
2013-03-27 |
3M Innovative Properties Company |
Immunostimulatory Combinations
|
JP2006517974A
(ja)
|
2003-02-13 |
2006-08-03 |
スリーエム イノベイティブ プロパティズ カンパニー |
Irm化合物およびトル様受容体8に関する方法および組成物
|
US7485432B2
(en)
*
|
2003-02-27 |
2009-02-03 |
3M Innovative Properties Company |
Selective modulation of TLR-mediated biological activity
|
CA2517528A1
(en)
|
2003-03-04 |
2004-09-16 |
3M Innovative Properties Company |
Prophylactic treatment of uv-induced epidermal neoplasia
|
US7163947B2
(en)
|
2003-03-07 |
2007-01-16 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
US20040176367A1
(en)
*
|
2003-03-07 |
2004-09-09 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
AU2004220465A1
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
WO2004080293A2
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Methods for diagnosing skin lesions
|
KR20050109562A
(ko)
|
2003-03-13 |
2005-11-21 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
피부의 질을 개선시키는 방법
|
US20040192585A1
(en)
*
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
JP2007500210A
(ja)
*
|
2003-04-10 |
2007-01-11 |
スリーエム イノベイティブ プロパティズ カンパニー |
金属含有微粒子担体材料を使用した免疫反応調節物質化合物の送達
|
WO2004096144A2
(en)
*
|
2003-04-28 |
2004-11-11 |
3M Innovative Properties Company |
Compositions and methods for induction of opioid receptors
|
US20050032829A1
(en)
*
|
2003-06-06 |
2005-02-10 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
US6943255B2
(en)
|
2003-06-06 |
2005-09-13 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
JP2007500713A
(ja)
*
|
2003-07-31 |
2007-01-18 |
スリーエム イノベイティブ プロパティズ カンパニー |
トリアジンを含む生理活性組成物
|
US20050070460A1
(en)
*
|
2003-08-05 |
2005-03-31 |
3M Innovative Properties Company |
Infection prophylaxis using immune response modifier compounds
|
JP2007502293A
(ja)
|
2003-08-12 |
2007-02-08 |
スリーエム イノベイティブ プロパティズ カンパニー |
ヒドロキシルアミン置換イミダゾ含有化合物
|
US7678909B1
(en)
*
|
2003-08-13 |
2010-03-16 |
Takeda Pharmaceutical Company Limited |
Dipeptidyl peptidase inhibitors
|
EP2939693A1
(en)
|
2003-08-14 |
2015-11-04 |
3M Innovative Properties Company |
Lipid-modified immune response modifiers
|
JP2007503268A
(ja)
*
|
2003-08-25 |
2007-02-22 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答修飾化合物の送達
|
JP2007504145A
(ja)
*
|
2003-08-25 |
2007-03-01 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫刺激性の組み合わせおよび治療
|
RU2006105101A
(ru)
*
|
2003-08-27 |
2007-10-10 |
3М Инновейтив Пропертиз Компани (US) |
Арилокси и арилалкиленокси замещенные имидазохинолины
|
EP1663222A4
(en)
*
|
2003-09-02 |
2008-05-21 |
3M Innovative Properties Co |
METHODS RELATING TO THE TREATMENT OF GIANCES
|
CA2537763A1
(en)
*
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for cd5+ b cell lymphoma
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
AU2004278014B2
(en)
*
|
2003-10-03 |
2011-04-28 |
3M Innovative Properties Company |
Alkoxy substituted imidazoquinolines
|
MY146124A
(en)
|
2003-10-03 |
2012-06-29 |
3M Innovative Properties Co |
Pyrazolopyridines and analogs thereof
|
US20090075980A1
(en)
*
|
2003-10-03 |
2009-03-19 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and Analogs Thereof
|
AU2004285575A1
(en)
*
|
2003-10-31 |
2005-05-12 |
3M Innovative Properties Company |
Neutrophil activation by immune response modifier compounds
|
JP2007511527A
(ja)
*
|
2003-11-14 |
2007-05-10 |
スリーエム イノベイティブ プロパティズ カンパニー |
オキシム置換イミダゾ環化合物
|
US8598192B2
(en)
|
2003-11-14 |
2013-12-03 |
3M Innovative Properties Company |
Hydroxylamine substituted imidazoquinolines
|
DE602004014969D1
(de)
*
|
2003-11-21 |
2008-08-21 |
Novartis Ag |
1h-imidazochinolinderivate als proteinkinaseinhibitoren
|
WO2005051317A2
(en)
|
2003-11-25 |
2005-06-09 |
3M Innovative Properties Company |
Substituted imidazo ring systems and methods
|
CA2547085A1
(en)
|
2003-11-25 |
2005-06-09 |
3M Innovative Properties Company |
Hydroxylamine and oxime substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
US8940755B2
(en)
|
2003-12-02 |
2015-01-27 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
US20050226878A1
(en)
*
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
JP2007513170A
(ja)
|
2003-12-04 |
2007-05-24 |
スリーエム イノベイティブ プロパティズ カンパニー |
スルホン置換イミダゾ環エーテル
|
AU2004312510A1
(en)
|
2003-12-29 |
2005-07-21 |
3M Innovative Properties Company |
Piperazine, [1,4]diazepane, [1,4]diazocane, and [1,5]diazocane fused imidazo ring compounds
|
WO2005066170A1
(en)
|
2003-12-29 |
2005-07-21 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
WO2005067500A2
(en)
*
|
2003-12-30 |
2005-07-28 |
3M Innovative Properties Company |
Enhancement of immune responses
|
CA2551399A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
WO2005087775A1
(ja)
*
|
2004-03-15 |
2005-09-22 |
Ono Pharmaceutical Co., Ltd. |
三環式複素環化合物およびその化合物を有効成分として含有する医薬組成物
|
ES2665342T3
(es)
|
2004-03-15 |
2018-04-25 |
Meda Ab |
Formulaciones y métodos para modificadores de la respuesta inmune
|
US8697873B2
(en)
|
2004-03-24 |
2014-04-15 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
US20070166384A1
(en)
*
|
2004-04-09 |
2007-07-19 |
Zarraga Isidro Angelo E |
Methods , composition and preparations for delivery of immune response modifiers
|
CA2564855A1
(en)
*
|
2004-04-28 |
2005-10-28 |
3M Innovative Properties Company |
Compositions and methods for mucosal vaccination
|
US20050267145A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
ES2560449T3
(es)
|
2004-05-28 |
2016-02-19 |
Oryxe |
Una mezcla para administración transdérmica de compuestos de peso molecular bajo y alto
|
WO2005123079A2
(en)
*
|
2004-06-14 |
2005-12-29 |
3M Innovative Properties Company |
Urea substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
US8017779B2
(en)
|
2004-06-15 |
2011-09-13 |
3M Innovative Properties Company |
Nitrogen containing heterocyclyl substituted imidazoquinolines and imidazonaphthyridines
|
JP5128940B2
(ja)
*
|
2004-06-18 |
2013-01-23 |
スリーエム イノベイティブ プロパティズ カンパニー |
置換イミダゾキノリン、イミダゾピリジン、およびイミダゾナフチリジン
|
US8541438B2
(en)
|
2004-06-18 |
2013-09-24 |
3M Innovative Properties Company |
Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
US7897609B2
(en)
|
2004-06-18 |
2011-03-01 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
US7915281B2
(en)
|
2004-06-18 |
2011-03-29 |
3M Innovative Properties Company |
Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and method
|
US20060045886A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Kedl Ross M |
HIV immunostimulatory compositions
|
ES2384390T3
(es)
|
2004-09-02 |
2012-07-04 |
3M Innovative Properties Company |
Sistemas cíclicos 1-alcoxi-1H-imidazo y métodos asociados
|
US20090270443A1
(en)
*
|
2004-09-02 |
2009-10-29 |
Doris Stoermer |
1-amino imidazo-containing compounds and methods
|
WO2006029115A2
(en)
|
2004-09-02 |
2006-03-16 |
3M Innovative Properties Company |
2-amino 1h imidazo ring systems and methods
|
US20080193468A1
(en)
*
|
2004-09-08 |
2008-08-14 |
Children's Medical Center Corporation |
Method for Stimulating the Immune Response of Newborns
|
US20070243215A1
(en)
*
|
2004-10-08 |
2007-10-18 |
Miller Richard L |
Adjuvant for Dna Vaccines
|
US7678912B2
(en)
*
|
2004-12-27 |
2010-03-16 |
Usv, Ltd. |
Process for preparation of 4-amino-1-isobutyl-1H-imidazo[4,5-C]-quinoline (Imiquimod)
|
JP5313502B2
(ja)
|
2004-12-30 |
2013-10-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
置換キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
|
CA2592897A1
(en)
*
|
2004-12-30 |
2006-07-13 |
Takeda Pharmaceutical Company Limited |
1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine ethanesulfonate and 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine methanesulfonate
|
JP5543068B2
(ja)
|
2004-12-30 |
2014-07-09 |
スリーエム イノベイティブ プロパティズ カンパニー |
キラル縮合[1,2]イミダゾ[4,5−c]環状化合物
|
PT1830876E
(pt)
|
2004-12-30 |
2015-07-13 |
Meda Ab |
Utilização de imiquimod para o tratamento de metástases cutâneas derivadas de um tumor cancerígeno da mama
|
US8436176B2
(en)
*
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
JP2008530022A
(ja)
|
2005-02-04 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
免疫反応調節物質を含む水性ゲル処方物
|
US7683171B2
(en)
|
2005-02-04 |
2010-03-23 |
Bristol-Myers Squibb Company |
1H-imidazo[4,5-d]thieno[3,2-b]pyridine based tricyclic compounds and pharmaceutical compositions comprising same
|
JP2008530252A
(ja)
|
2005-02-09 |
2008-08-07 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
オキシムおよびヒドロキシルアミンで置換されたチアゾロ[4,5−c]環化合物ならびに方法
|
EP1846419B1
(en)
|
2005-02-09 |
2014-04-16 |
3M Innovative Properties Company |
Alkoxy-substituted thiazoloquinolines and thiazolonaphthyridines
|
AU2006213746A1
(en)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Oxime and hydroxylamine substituted imidazo(4,5-c) ring compounds and methods
|
AU2006216997A1
(en)
|
2005-02-11 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Substituted imidazoquinolines and imidazonaphthyridines
|
JP2008531568A
(ja)
|
2005-02-23 |
2008-08-14 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ヒドロキシアルキルで置換されたイミダゾナフチリジン
|
AU2006223634A1
(en)
|
2005-02-23 |
2006-09-21 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinolines
|
JP2008538203A
(ja)
*
|
2005-02-23 |
2008-10-16 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
インターフェロンの生合成を優先的に誘導する方法
|
CA2598656A1
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinoline compounds and methods
|
BRPI0608011A2
(pt)
|
2005-03-14 |
2009-11-03 |
Graceway Pharmaceuticals Llc |
uso de uma formulação para o tratamento da queratose actìnica e uso de 2-metil-1-(2-metilpropil)-1h-imidazo[4,5-c][1,5] naftiridin-4-amina
|
AU2006232375A1
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
1-substituted pyrazolo (3,4-c) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
WO2006107853A2
(en)
|
2005-04-01 |
2006-10-12 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines and analogs thereof
|
US20080193474A1
(en)
*
|
2005-04-25 |
2008-08-14 |
Griesgraber George W |
Immunostimulatory Compositions
|
GB0510390D0
(en)
|
2005-05-20 |
2005-06-29 |
Novartis Ag |
Organic compounds
|
US20090221644A1
(en)
*
|
2005-06-30 |
2009-09-03 |
Stuart Edward Bradley |
Gpcr Agonists
|
CA2621831A1
(en)
|
2005-09-09 |
2007-03-15 |
Coley Pharmaceutical Group, Inc. |
Amide and carbamate derivatives of n-{2-[4-amino-2- (ethoxymethyl)-1h-imidazo[4,5-c]quinolin-1-yl]-1,1-dimethylethyl}methanesulfonamide and methods
|
ZA200803029B
(en)
|
2005-09-09 |
2009-02-25 |
Coley Pharm Group Inc |
Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
|
KR20080083270A
(ko)
*
|
2005-11-04 |
2008-09-17 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
하이드록시 및 알콕시 치환된 1에이치 이미다조퀴놀린 및방법
|
JP2009515884A
(ja)
*
|
2005-11-10 |
2009-04-16 |
スミスクライン・ビーチャム・コーポレイション |
Akt活性の阻害剤
|
WO2007058852A2
(en)
*
|
2005-11-10 |
2007-05-24 |
Smithkline Beecham Corporation |
Inhibitors of akt activity
|
HUE030235T2
(hu)
|
2005-12-13 |
2017-04-28 |
Incyte Holdings Corp |
Heteroaril-szubsztituált pirrolo[2,3-b]piridinek és pirrolo[2,3-b]pirimidinek mint Janus-kináz inhibitorok
|
WO2007093901A1
(en)
|
2006-02-17 |
2007-08-23 |
Pfizer Limited |
3 -deazapurine derivatives as tlr7 modulators
|
EP3085373A1
(en)
|
2006-02-22 |
2016-10-26 |
3M Innovative Properties Company |
Immune response modifier conjugates
|
US8329721B2
(en)
*
|
2006-03-15 |
2012-12-11 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
|
WO2008008432A2
(en)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Substituted chiral fused( 1,2) imidazo (4,5-c) ring compounds and methods
|
US8178539B2
(en)
|
2006-09-06 |
2012-05-15 |
3M Innovative Properties Company |
Substituted 3,4,6,7-tetrahydro-5H-1,2a,4a,8-tetraazacyclopenta[cd]phenalenes and methods
|
EA015677B1
(ru)
|
2006-11-20 |
2011-10-31 |
Новартис Аг |
СОЛИ И КРИСТАЛЛИЧЕСКИЕ ФОРМЫ 2-МЕТИЛ-2-[4-(3-МЕТИЛ-2-ОКСО-8-ХИНОЛИН-3-ИЛ-2,3-ДИГИДРОИМИДАЗО[4,5-c]ХИНОЛИН-1-ИЛ)ФЕНИЛ]ПРОПИОНИТРИЛА
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
EP3070090B1
(en)
|
2007-06-13 |
2018-12-12 |
Incyte Holdings Corporation |
Use of salts of the janus kinase inhibitor (r)-3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h- pyrazol-1-yl)-3- cyclopentylpropanenitrile
|
GB0715428D0
(en)
*
|
2007-08-08 |
2007-09-19 |
Imp Innovations Ltd |
Compositions and uses thereof
|
WO2009125808A1
(ja)
*
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
アミノシクロヘキシル誘導体
|
WO2009125809A1
(ja)
*
|
2008-04-11 |
2009-10-15 |
第一三共株式会社 |
ピペリジン誘導体
|
AR076794A1
(es)
|
2009-05-22 |
2011-07-06 |
Incyte Corp |
Derivados de n-(hetero)aril-pirrolidina de pirazol-4-il-pirrolo [2,3-d]pirimidinas y pirrol-3-il-pirrolo [2,3-d ]pirimidinas como inhibidores de la quinasa janus y composiciones farmaceuticas que los contienen
|
EA020494B1
(ru)
|
2009-05-22 |
2014-11-28 |
Инсайт Корпорейшн |
3-[4-(7H-ПИРРОЛО[2,3-d]ПИРИМИДИН-4-ИЛ)-1H-ПИРАЗОЛ-1-ИЛ]ОКТАН- ИЛИ ГЕПТАННИТРИЛ КАК JAK-ИНГИБИТОРЫ
|
US20110033515A1
(en)
*
|
2009-08-04 |
2011-02-10 |
Rst Implanted Cell Technology |
Tissue contacting material
|
AR078012A1
(es)
|
2009-09-01 |
2011-10-05 |
Incyte Corp |
Derivados heterociclicos de las pirazol-4-il- pirrolo (2,3-d) pirimidinas como inhibidores de la quinasa janus
|
MX347851B
(es)
|
2010-03-10 |
2017-05-16 |
Incyte Corp |
Derivados de piperidin-4-il azetidina como inhibidores de janus cinasa 1 (jak1).
|
EP3087972A1
(en)
|
2010-05-21 |
2016-11-02 |
Incyte Holdings Corporation |
Topical formulation for a jak inhibitor
|
ES2617451T3
(es)
|
2010-08-17 |
2017-06-19 |
3M Innovative Properties Company |
Composiciones lipidadas de compuestos modificadores de la respuesta inmunitaria, formulaciones, y métodos
|
SG190839A1
(en)
|
2010-11-19 |
2013-07-31 |
Incyte Corp |
Cyclobutyl substituted pyrrolopyridine and pyrrolopyrimidine derivatives as jak inhibitors
|
MX2013006284A
(es)
*
|
2010-12-06 |
2013-10-28 |
Piramal Entpr Ltd |
Derivados sustituidos de imidazoquinolina.
|
EP3366311B1
(en)
|
2011-06-03 |
2020-02-26 |
3M Innovative Properties Co. |
Hydrazino-1h-imidazoquinolin-4-amines and conjugates made therefrom
|
WO2012167088A1
(en)
|
2011-06-03 |
2012-12-06 |
3M Innovative Properties Company |
Heterobifunctional linkers with polyethylene glycol segments and immune response modifier conjugates made therefrom
|
AR086983A1
(es)
|
2011-06-20 |
2014-02-05 |
Incyte Corp |
Derivados de azetidinil fenil, piridil o pirazinil carboxamida como inhibidores de jak
|
US20130023736A1
(en)
|
2011-07-21 |
2013-01-24 |
Stanley Dale Harpstead |
Systems for drug delivery and monitoring
|
TW201313721A
(zh)
|
2011-08-18 |
2013-04-01 |
Incyte Corp |
作為jak抑制劑之環己基氮雜環丁烷衍生物
|
UA111854C2
(uk)
|
2011-09-07 |
2016-06-24 |
Інсайт Холдінгс Корпорейшн |
Способи і проміжні сполуки для отримання інгібіторів jak
|
HUE040374T2
(hu)
|
2011-09-30 |
2019-03-28 |
C&C Res Lab |
Új heterociklusos származékok és alkalmazásaik
|
IN2014KN00948A
(hu)
|
2011-10-04 |
2015-08-21 |
Janus Biotherapeutics Inc |
|
US10076535B2
(en)
|
2012-04-27 |
2018-09-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Use of CPG oligonucleotides co-formulated with an antibiotic to accelerate wound healing
|
AR091079A1
(es)
|
2012-05-18 |
2014-12-30 |
Incyte Corp |
Derivados de pirrolopirimidina y pirrolopiridina sustituida con piperidinilciclobutilo como inhibidores de jak
|
NZ707495A
(en)
|
2012-11-01 |
2019-01-25 |
Incyte Holdings Corp |
Tricyclic fused thiophene derivatives as jak inhibitors
|
KR20220162825A
(ko)
|
2012-11-15 |
2022-12-08 |
인사이트 홀딩스 코포레이션 |
룩솔리티니브의 서방성 제형
|
KR20150103718A
(ko)
|
2013-01-07 |
2015-09-11 |
더 트러스티스 오브 더 유니버시티 오브 펜실바니아 |
피부 t 세포 림프종 치료를 위한 조성물 및 방법
|
AU2014225938B2
(en)
|
2013-03-06 |
2018-07-19 |
Incyte Holdings Corporation |
Processes and intermediates for making a JAK inhibitor
|
WO2014201245A1
(en)
|
2013-06-12 |
2014-12-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tlr-9 agonist with tlr-7 and/or tlr-8 agonist for treating tumors
|
KR20160045081A
(ko)
|
2013-08-07 |
2016-04-26 |
인사이트 코포레이션 |
Jak1 억제제용 지속 방출 복용 형태
|
US9227969B2
(en)
*
|
2013-08-14 |
2016-01-05 |
Novartis Ag |
Compounds and compositions as inhibitors of MEK
|
TW201625643A
(zh)
|
2014-04-30 |
2016-07-16 |
英塞特公司 |
製備jak1抑制劑之方法及其新形式
|
WO2015171526A2
(en)
*
|
2014-05-05 |
2015-11-12 |
Global Blood Therapeutics, Inc. |
Tricyclic pyrazolopyridine compounds
|
WO2015184305A1
(en)
|
2014-05-30 |
2015-12-03 |
Incyte Corporation |
TREATMENT OF CHRONIC NEUTROPHILIC LEUKEMIA (CNL) AND ATYPICAL CHRONIC MYELOID LEUKEMIA (aCML) BY INHIBITORS OF JAK1
|
WO2016183371A1
(en)
|
2015-05-13 |
2016-11-17 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Methods for the treatment or prevention of ischemic tissue damage
|
WO2017044803A1
(en)
|
2015-09-09 |
2017-03-16 |
The United States Of America, As Represented By The Secretary Department Of Health And Human Service |
Expression vector delivery system and use thereof for inducing an immune response
|
US11260018B2
(en)
|
2015-09-17 |
2022-03-01 |
Jrx Biotechnology, Inc. |
Approaches for improving skin hydration and moisturization
|
WO2017059280A1
(en)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Novel pan-tam inhibitors and mer/axl dual inhibitors
|
US11191821B2
(en)
|
2016-02-27 |
2021-12-07 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Peptide vaccine formulations and use thereof for inducing an immune response
|
NZ751284A
(en)
|
2016-10-03 |
2022-09-30 |
Hangzhou Highlightll Pharmaceutical Co Ltd |
Novel jak1 selective inhibitors and uses thereof
|
WO2018128407A1
(ko)
*
|
2017-01-06 |
2018-07-12 |
고려대학교 세종산학협력단 |
신규한 퀴놀리논 유도체 및 이를 유효성분으로 포함하는 천식 또는 아토피 등의 알러지성 질환의 예방 또는 치료용 약학 조성물
|
EP3567044A4
(en)
|
2017-01-06 |
2020-06-10 |
Korea University Research and Business Foundation, Sejong Campus |
INNOVATIVE CHINOLINONE DERIVATIVE AND PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF ALLERGIC DISEASES LIKE ASTHMA OR ATOPIA THEREFORE AS AN ACTIVE SUBSTANCE
|
JP2020515629A
(ja)
|
2017-04-04 |
2020-05-28 |
アヴィディア テクノロジーズ, インコーポレイテッド |
免疫応答を誘導するためのペプチドベースのワクチン、それらの製造方法および使用
|
TW201924683A
(zh)
|
2017-12-08 |
2019-07-01 |
美商英塞特公司 |
用於治療骨髓增生性贅瘤的低劑量組合療法
|
JP7197244B2
(ja)
|
2017-12-20 |
2022-12-27 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答調節剤として使用するための分岐鎖連結基を有するアミド置換イミダゾ[4,5-c]キノリン化合物
|
TWI797242B
(zh)
|
2018-01-30 |
2023-04-01 |
美商英塞特公司 |
製備jak抑制劑之方法及中間物
|
JP2021516045A
(ja)
|
2018-02-28 |
2021-07-01 |
ファイザー・インク |
Il−15バリアントおよびその使用
|
MX2022012285A
(es)
|
2018-03-30 |
2023-08-15 |
Incyte Corp |
Tratamiento de la hidradenitis supurativa mediante el uso de inhibidores de actividad de la cinasa janus (jak).
|
AU2019272844A1
(en)
|
2018-05-22 |
2021-01-21 |
Barinthus Biotherapeutics North America, Inc. |
Improved methods of manufacturing peptide-based vaccines
|
TWI793325B
(zh)
|
2018-05-23 |
2023-02-21 |
美商輝瑞大藥廠 |
對cd3具特異性之抗體及其用途
|
TWI816396B
(zh)
|
2018-05-23 |
2023-09-21 |
美商輝瑞大藥廠 |
特異性針對gucy2c之抗體及其用途
|
WO2020061564A1
(en)
|
2018-09-23 |
2020-03-26 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Hiv-1 env fusion peptide nanoparticle carrier conjugates and their use
|
AU2019355926A1
(en)
|
2018-10-03 |
2021-04-22 |
Barinthus Biotherapeutics North America, Inc. |
Aromatic ring substituted amphiphilic polymers as drug delivery systems
|
WO2020128893A1
(en)
|
2018-12-21 |
2020-06-25 |
Pfizer Inc. |
Combination treatments of cancer comprising a tlr agonist
|
AU2020260131A1
(en)
|
2019-04-17 |
2021-11-18 |
Barinthus Biotherapeutics North America, Inc. |
Compositions and methods of manufacturing star polymers for ligand display and/or drug delivery
|
WO2021124073A1
(en)
|
2019-12-17 |
2021-06-24 |
Pfizer Inc. |
Antibodies specific for cd47, pd-l1, and uses thereof
|
US11833155B2
(en)
|
2020-06-03 |
2023-12-05 |
Incyte Corporation |
Combination therapy for treatment of myeloproliferative neoplasms
|
AU2021308586A1
(en)
|
2020-07-17 |
2023-03-02 |
Pfizer Inc. |
Therapeutic antibodies and their uses
|
AU2021347147A1
(en)
|
2020-09-22 |
2023-05-18 |
Barinthus Biotherapeutics North America, Inc. |
Compositions and methods of manufacturing amphiphilic block copolymers that form nanoparticles in situ
|
CA3195623A1
(en)
|
2020-10-19 |
2022-04-28 |
Geoffrey Martin Lynn |
Star polymer drug conjugates
|
EP4263553A1
(en)
*
|
2020-12-17 |
2023-10-25 |
Zymeworks BC Inc. |
Imidazothienopyridine compounds and methods of use
|
JP2024506381A
(ja)
|
2021-02-16 |
2024-02-13 |
ヴァクシテック ノース アメリカ, インコーポレイテッド |
両親媒性ペプチドに基づく自己集合ナノ粒子
|
WO2024092028A2
(en)
|
2022-10-25 |
2024-05-02 |
Vaccitech North America, Inc. |
Combination treatment regimes for treating cancer
|
WO2024092030A1
(en)
|
2022-10-25 |
2024-05-02 |
Vaccitech North America, Inc. |
Self-assembling nanoparticles
|
WO2024100093A1
(en)
|
2022-11-09 |
2024-05-16 |
Merck Patent Gmbh |
Toll-like receptor 7 agonists as immune-stimulators to elicit the innate antitumor immunity
|